Kent Armeson to Cell Line, Tumor
This is a "connection" page, showing publications Kent Armeson has written about Cell Line, Tumor.
Connection Strength
0.229
-
SWAN pathway-network identification of common aneuploidy-based oncogenic drivers. Nucleic Acids Res. 2022 04 22; 50(7):3673-3692.
Score: 0.034
-
Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.
Score: 0.029
-
HUNK phosphorylates EGFR to regulate breast cancer metastasis. Oncogene. 2020 01; 39(5):1112-1124.
Score: 0.029
-
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019 Feb; 173(3):559-571.
Score: 0.027
-
A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival. Nat Cell Biol. 2018 01; 20(1):104-115.
Score: 0.025
-
The neuropilin 2 isoform NRP2b uniquely supports TGF?-mediated progression in lung cancer. Sci Signal. 2017 01 17; 10(462).
Score: 0.024
-
Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control. Oncotarget. 2016 Oct 25; 7(43):69371-69383.
Score: 0.024
-
Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse. J Clin Invest. 2013 Oct; 123(10):4344-58.
Score: 0.019
-
Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B. Int J Cancer. 2012 Nov 01; 131(9):2034-43.
Score: 0.017